Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Diseases & treatment Market Research Reports

Titlepublishedprice

Investigation Report on China Pemetrexed Market, 2009-2018

By China Research and Intelligence
"...... rst drug approved by FDA to treat the disease. In August 2004 pemetrexed was approved as a secondline drug for local or metastatic nonsmall cell lung cancer. So far pemetrexed (brand name "Alimta") has been approved to more than 60 countries world......"
28-Feb-2014$1800

Investigation Report on China Quetiapine Market, 2009-2018

By China Research and Intelligence
"...... also increased. Statistics shows that the number of schizophrene in China has exceeded 10 million by the end of 2013, and it is still rising year after year. Quetiapine is originally developed by Astra Zeneca and has curative effect on various sch......"
28-Feb-2014$1800

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2022

By GlobalData
"...... and cognitive deficits. WHO experts have estimated that roughly 24 million people are affected by schizophrenia worldwide. While the arrival of atypical antipsychotics has greatly expanded pharmacologic treatment options over the past two decades, th......"
28-Feb-2014$10995

PharmaPoint: Schizophrenia - Current and Future Players

By GlobalData
"...... g and driving the global Schizophrenia market. The report provides insight into the competitive Schizophrenia landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, ......"
28-Feb-2014$2995

Alzheimer's Disease - Pipeline Review, H1 2014

By Global Markets Direct
"...... therapeutic development for Alzheimer's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and ......"
28-Feb-2014$2500

Rheumatoid Arthritis - Pipeline Review, H1 2014

By Global Markets Direct
"...... he therapeutic development for Rheumatoid Arthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, ......"
28-Feb-2014$2500

Type 2 Diabetes - Pipeline Review, H1 2014

By Global Markets Direct
"...... development for Type 2 Diabetes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news an......"
28-Feb-2014$2500

Parkinson's Disease - Pipeline Review, H1 2014

By Global Markets Direct
"...... therapeutic development for Parkinson's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and ......"
28-Feb-2014$2500

Hepatitis C - Pipeline Review, H1 2014

By Global Markets Direct
"...... for Hepatitis C, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases......"
28-Feb-2014$2500

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014

By Global Markets Direct
"...... peline. This report provides comprehensive information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechani......"
28-Feb-2014$2000

Avail upto 25% Discount on below Publisher Reports.